ENOVIS CORP (ENOV) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ENOV • US1940141062

22.17 USD
+0.13 (+0.59%)
At close: Feb 2, 2026
22.17 USD
0 (0%)
After Hours: 2/2/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, ENOV scores 4 out of 10 in our fundamental rating. ENOV was compared to 186 industry peers in the Health Care Equipment & Supplies industry. ENOV has a medium profitability rating, but doesn't score so well on its financial health evaluation. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ENOV was profitable.
  • ENOV had a positive operating cash flow in the past year.
  • In multiple years ENOV reported negative net income over the last 5 years.
  • ENOV had a positive operating cash flow in 4 of the past 5 years.
ENOV Yearly Net Income VS EBIT VS OCF VS FCFENOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

1.2 Ratios

  • With a Return On Assets value of -30.84%, ENOV perfoms like the industry average, outperforming 43.01% of the companies in the same industry.
  • ENOV has a Return On Equity of -67.66%. This is comparable to the rest of the industry: ENOV outperforms 45.70% of its industry peers.
  • The Return On Invested Capital of ENOV (0.12%) is better than 65.05% of its industry peers.
Industry RankSector Rank
ROA -30.84%
ROE -67.66%
ROIC 0.12%
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ENOV Yearly ROA, ROE, ROICENOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • The Operating Margin of ENOV (0.25%) is better than 65.05% of its industry peers.
  • In the last couple of years the Operating Margin of ENOV has declined.
  • With a Gross Margin value of 57.19%, ENOV perfoms like the industry average, outperforming 56.99% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ENOV has grown nicely.
Industry RankSector Rank
OM 0.25%
PM (TTM) N/A
GM 57.19%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
ENOV Yearly Profit, Operating, Gross MarginsENOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
  • Compared to 1 year ago, ENOV has more shares outstanding
  • ENOV has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ENOV has a worse debt to assets ratio.
ENOV Yearly Shares OutstandingENOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENOV Yearly Total Debt VS Total AssetsENOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.72, we must say that ENOV is in the distress zone and has some risk of bankruptcy.
  • ENOV has a Altman-Z score (0.72) which is in line with its industry peers.
  • The Debt to FCF ratio of ENOV is 59.72, which is on the high side as it means it would take ENOV, 59.72 years of fcf income to pay off all of its debts.
  • ENOV's Debt to FCF ratio of 59.72 is fine compared to the rest of the industry. ENOV outperforms 67.20% of its industry peers.
  • ENOV has a Debt/Equity ratio of 0.66. This is a neutral value indicating ENOV is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ENOV (0.66) is worse than 65.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 59.72
Altman-Z 0.72
ROIC/WACC0.01
WACC9.77%
ENOV Yearly LT Debt VS Equity VS FCFENOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.22 indicates that ENOV has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.22, ENOV perfoms like the industry average, outperforming 43.55% of the companies in the same industry.
  • ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
  • ENOV's Quick ratio of 1.16 is on the low side compared to the rest of the industry. ENOV is outperformed by 69.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 1.16
ENOV Yearly Current Assets VS Current LiabilitesENOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.14% over the past year.
  • The earnings per share for ENOV have been decreasing by -16.18% on average. This is quite bad
  • The Revenue has grown by 11.57% in the past year. This is quite good.
  • ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.19% on average over the next years. This is a very strong growth
  • ENOV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.87% yearly.
EPS Next Y14.57%
EPS Next 2Y11.17%
EPS Next 3Y11.67%
EPS Next 5Y23.19%
Revenue Next Year7.37%
Revenue Next 2Y5.98%
Revenue Next 3Y6.01%
Revenue Next 5Y8.87%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENOV Yearly Revenue VS EstimatesENOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ENOV Yearly EPS VS EstimatesENOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.66 indicates a rather cheap valuation of ENOV.
  • ENOV's Price/Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 98.39% of the companies in the same industry.
  • ENOV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.41.
  • A Price/Forward Earnings ratio of 6.34 indicates a rather cheap valuation of ENOV.
  • Based on the Price/Forward Earnings ratio, ENOV is valued cheaply inside the industry as 98.39% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 25.64. ENOV is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.66
Fwd PE 6.34
ENOV Price Earnings VS Forward Price EarningsENOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaply inside the industry as 93.55% of the companies are valued more expensively.
  • ENOV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ENOV is cheaper than 72.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 55.7
EV/EBITDA 8.72
ENOV Per share dataENOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y11.17%
EPS Next 3Y11.67%

More info and screens

0

5. Dividend

5.1 Amount

  • ENOV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ENOVIS CORP

NYSE:ENOV (2/2/2026, 8:04:00 PM)

After market: 22.17 0 (0%)

22.17

+0.13 (+0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners117.36%
Inst Owner Change-2.32%
Ins Owners1.14%
Ins Owner Change0.81%
Market Cap1.27B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.53
Price Target46.36 (109.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-3.29%
PT rev (3m)-12.17%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)-5.21%
EPS NY rev (1m)-0.09%
EPS NY rev (3m)1.76%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.37%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 6.66
Fwd PE 6.34
P/S 0.57
P/FCF 55.7
P/OCF 5.84
P/B 0.63
P/tB N/A
EV/EBITDA 8.72
EPS(TTM)3.33
EY15.02%
EPS(NY)3.5
Fwd EY15.77%
FCF(TTM)0.4
FCFY1.8%
OCF(TTM)3.8
OCFY17.12%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.46
PEG (5Y)N/A
Graham Number51.45
Profitability
Industry RankSector Rank
ROA -30.84%
ROE -67.66%
ROCE 0.15%
ROIC 0.12%
ROICexc 0.12%
ROICexgc 0.34%
OM 0.25%
PM (TTM) N/A
GM 57.19%
FCFM 1.02%
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 59.72
Debt/EBITDA 4.5
Cap/Depr 66.6%
Cap/Sales 8.7%
Interest Coverage 250
Cash Conversion 72.98%
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 1.16
Altman-Z 0.72
F-Score4
WACC9.77%
ROIC/WACC0.01
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y14.57%
EPS Next 2Y11.17%
EPS Next 3Y11.67%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.37%
Revenue Next 2Y5.98%
Revenue Next 3Y6.01%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.65%
EBIT Next 3Y28.13%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%

ENOVIS CORP / ENOV FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.


What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.


Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.


What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.57% in the next year.